California Cancer Reporting System Standards, Volume III

TNM Clin T

IDENTIFIERS

OWNER

AJCC

DESCRIPTION

Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor prior to the start of any therapy.

LEVEL

Tumors, Admissions

LENGTH

4

ALLOWABLE VALUES

er142 TNM Clin T

er1159: TNM Clin T, Date of Diagnosis (COC)

IF1185: TNM Clin T, Clin Size, Site Spec – Ed 7 (SEER)

Codes in addition to those published in the AJCC Cancer Stating Manual:

Note: See the AJCC Cancer Staging Manual, current edition for site-specific categories for the TNM elements and stage groups.  See the FORDS manual for specifications for codes and data entry rules.

SOURCE

If Coding Procedure is less than 33, then

1. Execute the same conversions from use case Perform Eureka 2016 One-Time Data Conversions and Table Populations – UC, step 3, for the new admission.

UPDATE

TNM Clin Fields Update Logic

CONSOLIDATED DATA EXTRACT

Yes

To choose the proper values to submit to the State, the fields must be grouped into meaningful clusters, in which all the fields must come from the same report. Therefore, the following groups:

• the first T,N,M, and AJCSTAGE, for clinically-based staging
• the second T,N,M, and AJCSTAGE, for pathologic-based staging

For each group listed above, start with the most recent (i.e., latest admission date) analytic admission (class of case =10-22) and work back, until an admission is found with all non-blank values in the group (no item in the group is missing). In other words, only send values when they are non-blank for all variables considered in the group. However, if there is no qualifying analytic group send the values from the most recent non-blank, non-analytic admission.

The only exception to the above rule is if no TNM is found by that method, but there is an AJCC Stage, then send in the AJCC Stage from the latest analytic admission.

INTERFIELD EDITS

IF1129:TNM Edition Number, TNM Fields

IF1134: Primary Site, AJCC T-Ed 7, ICDO3

IF1164: Primary Site, T 2016 – Ed 7, ICDO3

IF1165: Primary Site, TNM Clin Stage Valid A – Ed 7 (COC)

IF1166: Primary Site, TNM Clin Stage Valid B – Ed 7 (COC)

IF1168: Primary Site, TNM Path Stage Valid B – Ed 7 (COC)

IF1187: TNM Groups Not Stageable - Insitu (COC)

IF1217: TNM T, Breast, Inflam Carcinoma (COC)

IF1218: TNM T, Clin and Path Stage, Behavior 2 (COC)

IF1219: TNM T, Clin and Path Stage, Behavior 3 (COC)

IF1220: TNM T, Deep Sites Soft Tissue (COC)

IF1221: TNM T, Descriptor, SSF 1 Thyroid (COC)

IF1223: TNM T, N, M, In Situ (COC)

IF1224: TNM T, Size, Uveal Melanoma (COC)

IF1225: TNM T, SSF 1 Conjuctiva (COC)

IF1228: TNM T, SSF 12, Tumor Size, Carcinoma of Skin (COC)

IF1229: TNM T, SSF 6 Skin of Eyelid (COC)

IF1230: TNM T, SSF 6, Breast (COC)

IF1231: TNM T, Size, Site Spec – Ed 7, ICDO3 (COC)

IF1234: Tumor Size Clinical, TNM Clin T (SEER)

IF1241: Tumor Size Summary, TNM Clin/Path T (COC)

IF1242: TNM Groups Beh 3 with Insitu 88 (COC)

IF1245: TNM Clin T,N,M,In Situ (COC)

HISTORICAL CHANGES